MANDY MYNHIER: Open Payments
NPI 1285829556 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 48 payments from 23 companies in 2025. Trend: 2023 $1,673 · 2024 $1,202 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $165 |
| Merck Sharp & Dohme LLC | 4 | $88 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: VERQUVO, UBRELVY, QULIPTA, Auvelity, LEQVIO, XIFAXAN, Wegovy, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
